# A Study of the Safety and Efficacy of SK-0503 for Diabetic Macular Edema

> **NCT00308542** · PHASE1,PHASE2 · COMPLETED · sponsor: **Sanwa Kagaku Kenkyusho Co., Ltd.**

## Conditions studied

- Diabetic Macular Edema

## Interventions

- **DRUG:** dexamethasone

## Key facts

- **NCT ID:** NCT00308542
- **Lead sponsor:** Sanwa Kagaku Kenkyusho Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2012-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00308542

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00308542, "A Study of the Safety and Efficacy of SK-0503 for Diabetic Macular Edema". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00308542. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*